U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C14H12F3N3O5
Molecular Weight 359.2574
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of PRETOMANID

SMILES

[O-][N+](=O)C1=CN2C[C@@H](COC2=N1)OCC3=CC=C(OC(F)(F)F)C=C3

InChI

InChIKey=ZLHZLMOSPGACSZ-NSHDSACASA-N
InChI=1S/C14H12F3N3O5/c15-14(16,17)25-10-3-1-9(2-4-10)7-23-11-5-19-6-12(20(21)22)18-13(19)24-8-11/h1-4,6,11H,5,7-8H2/t11-/m0/s1

HIDE SMILES / InChI

Approval Year

Unknown
86413
Name Type Language
PRETOMANID
INN   USAN   WHO-DD  
INN   USAN  
Official Name English
(S)-2-NITRO-6-(4-(TRIFLUOROMETHOXY)BENZYLOXY)-6,7-DIHYDRO-5H-IMIDAZO(2,1-B)(1,3)OXAZINE
Systematic Name English
PA-824
Code English
Pretomanid [WHO-DD]
Common Name English
pretomanid [INN]
Common Name English
PA 824
Code English
PRETOMANID [ORANGE BOOK]
Common Name English
(3S)-3-(4-TRIFLUOROMETHOXYBENZYLOXY)-6-NITRO-2H-3,4-DIHYDROIMIDAZO(2,1-B)OXAZINE
Common Name English
PRETOMANID [MI]
Common Name English
PRETOMANID [USAN]
Common Name English
PA824
Code English
Classification Tree Code System Code
EU-Orphan Drug EU/3/07/513
Created by admin on Sat Dec 16 02:15:53 UTC 2023 , Edited by admin on Sat Dec 16 02:15:53 UTC 2023
FDA ORPHAN DRUG 243107
Created by admin on Sat Dec 16 02:15:53 UTC 2023 , Edited by admin on Sat Dec 16 02:15:53 UTC 2023
Code System Code Type Description
DRUG BANK
DB05154
Created by admin on Sat Dec 16 02:15:53 UTC 2023 , Edited by admin on Sat Dec 16 02:15:53 UTC 2023
PRIMARY
DAILYMED
2XOI31YC4N
Created by admin on Sat Dec 16 02:15:53 UTC 2023 , Edited by admin on Sat Dec 16 02:15:53 UTC 2023
PRIMARY
DRUG CENTRAL
5344
Created by admin on Sat Dec 16 02:15:53 UTC 2023 , Edited by admin on Sat Dec 16 02:15:53 UTC 2023
PRIMARY
WIKIPEDIA
Pretomanid
Created by admin on Sat Dec 16 02:15:53 UTC 2023 , Edited by admin on Sat Dec 16 02:15:53 UTC 2023
PRIMARY
CAS
187235-37-6
Created by admin on Sat Dec 16 02:15:53 UTC 2023 , Edited by admin on Sat Dec 16 02:15:53 UTC 2023
PRIMARY
EPA CompTox
DTXSID8041163
Created by admin on Sat Dec 16 02:15:53 UTC 2023 , Edited by admin on Sat Dec 16 02:15:53 UTC 2023
PRIMARY
ChEMBL
CHEMBL227875
Created by admin on Sat Dec 16 02:15:53 UTC 2023 , Edited by admin on Sat Dec 16 02:15:53 UTC 2023
PRIMARY
MERCK INDEX
m12157
Created by admin on Sat Dec 16 02:15:53 UTC 2023 , Edited by admin on Sat Dec 16 02:15:53 UTC 2023
PRIMARY
FDA UNII
2XOI31YC4N
Created by admin on Sat Dec 16 02:15:53 UTC 2023 , Edited by admin on Sat Dec 16 02:15:53 UTC 2023
PRIMARY
INN
9871
Created by admin on Sat Dec 16 02:15:53 UTC 2023 , Edited by admin on Sat Dec 16 02:15:53 UTC 2023
PRIMARY
PUBCHEM
456199
Created by admin on Sat Dec 16 02:15:53 UTC 2023 , Edited by admin on Sat Dec 16 02:15:53 UTC 2023
PRIMARY
SMS_ID
100000141666
Created by admin on Sat Dec 16 02:15:53 UTC 2023 , Edited by admin on Sat Dec 16 02:15:53 UTC 2023
PRIMARY
LACTMED
Pretomanid
Created by admin on Sat Dec 16 02:15:53 UTC 2023 , Edited by admin on Sat Dec 16 02:15:53 UTC 2023
PRIMARY
RXCUI
2198359
Created by admin on Sat Dec 16 02:15:53 UTC 2023 , Edited by admin on Sat Dec 16 02:15:53 UTC 2023
PRIMARY
NCI_THESAURUS
C166606
Created by admin on Sat Dec 16 02:15:53 UTC 2023 , Edited by admin on Sat Dec 16 02:15:53 UTC 2023
PRIMARY
USAN
BC-53
Created by admin on Sat Dec 16 02:15:53 UTC 2023 , Edited by admin on Sat Dec 16 02:15:53 UTC 2023
PRIMARY
EVMPD
SUB96086
Created by admin on Sat Dec 16 02:15:53 UTC 2023 , Edited by admin on Sat Dec 16 02:15:53 UTC 2023
PRIMARY
ACTIVE MOIETY
Structure of PRETOMANID
METABOLITE (PARENT)
Structure of 2-HYDROXYIMIDAZOLE
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966